💊 Drug Interaction & Contraceptive Efficacy Simulator

Baseline Contraceptive Hormone Level

Placeholder: steady-state hormone level maintains contraceptive protection.

• 100%: Baseline hormone level (Placeholder reference level)
• ~24h: Typical half-life (Placeholder pharmacokinetic value)
• 40%: Protective threshold (Placeholder minimum level)
• <1%: Failure risk at baseline (Placeholder typical efficacy)

Normal hormonal contraceptive pharmacokinetics

Placeholder: daily dosing keeps hormone levels well above threshold.

Enzyme-Inducing Drug Introduced

Placeholder: rifampicin or anticonvulsants are started alongside the pill.

• High: Rifampicin induction strength (Placeholder classification)
• Moderate: Anticonvulsant induction (Placeholder classification)
• ~days: Onset of induction (Placeholder onset window)
• 2+: Common culprits (Placeholder drug class count)

Common enzyme-inducing drug classes

Placeholder: rifamycins and older anticonvulsants are classic inducers.

CYP450 Liver Enzyme Activation

Placeholder: hepatic CYP3A4 expression rises with sustained drug exposure.

• CYP3A4: Key enzyme (Placeholder principal isoform)
• PXR/CAR: Induction mechanism (Placeholder nuclear receptor pathway)
• ~1-2 wk: Peak induction time (Placeholder ramp-up period)
• up to 5x: Activity increase (Placeholder magnitude)

Nuclear receptor-driven enzyme induction

Placeholder: PXR activation upregulates CYP450 gene transcription.

Accelerated Hormone Metabolism

Placeholder: induced enzymes clear contraceptive hormones much faster.

• shortened: Effective half-life (Placeholder pharmacokinetic shift)
• increased: Clearance rate (Placeholder metabolic rate change)
• estrogen/progestin: Affected hormones (Placeholder hormone types)
• ~1 wk: Time to steady decline (Placeholder onset estimate)

Accelerated first-pass hepatic clearance

Placeholder: more enzyme molecules metabolize hormone faster per hour.

Contraceptive Protection Threshold Breach

Placeholder: hormone level drops below the level needed to block ovulation.

• 40%: Protective threshold (Placeholder minimum level)
• high: Failure risk at breach (Placeholder risk category)
• backup method: Recommended action (Placeholder clinical guidance)
• documented: Reported failures (Placeholder literature note)

Clinical significance of threshold breach

Placeholder: breakthrough ovulation risk rises once level falls below threshold.

Placeholder: patients on inducers should use backup contraception.